Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

Medical Updates & Immunization Site Training for All Healthcare Providers led by Pfizer Vaccines US Medical Affairs

Goal:  Educate providers and immunization staff personnel on the proper use of the Pfizer-BioNTech COVID-19 Vaccine


Session Topics Include:

  • FDA approvals, authorizations - including recent authorizations
    • Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine for individuals 6 months through 4 years of age (DILUTE BEFORE USE/Maroon Cap)
    • Approval COMIRNATY® for 12-15 years of age
  • Now available: Gray Cap, Comirnaty® (COVID-19 Vaccine, mRNA)
  • Use of each vaccine presentation, including storage, handling, preparation, and administration
  • Question and answer session


Sessions will be updated to reflect the latest information.

Join the sessions at the designated times listed below:

Schedule through August 2022*. Please check back for future training session information.


*Dates subject to change

 Date & Time


Attendee link – Tuesday, August 02 - 3pm ET


Attendee link – Wednesday, August 03 - 12pm ET


Attendee link – Thursday, August 04 - 12pm ET




Attendee link - Tuesday, August 09 - 3pm ET


Attendee link - Wednesday, August 10 - 12pm ET


Attendee link - Thursday, August 11 - 12pm ET




Attendee link - Tuesday, August 16 - 3pm ET


Attendee link - Wednesday, August 17 - 12pm ET


Attendee link - Thursday, August 18 - 12pm ET




Attendee Link- Tuesday, August 23 - 3pm ET


Attendee link – Wednesday, August 24 - 12pm ET


Attendee link - Thursday, August 25 - 12pm ET




Attendee link - Tuesday, August 30 - 3pm ET


Attendee link - Wednesday, August 31 - 12pm ET




Continuing medical education is NOT associated with this event

Emergency uses of the vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 6 months of age and older.  The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see EUA Fact Sheets at

Before administration of the vaccine, please see full Prescribing Information: 12+ years of age (DILUTE BEFORE USE/Purple Cap) and 12+ years of age (DO NOT DILUTE/Gray Cap) and EUA Fact Sheets for Vaccination Providers: 12+ years of age (DILUTE BEFORE USE/Purple Cap), 12+ years of age (DO NOT DILUTE/Gray Cap) and 5 through 11 years of age (DILUTE BEFORE USE/Orange Cap) and 6 months through 4 years of age (DILUTE BEFORE USE/Maroon Cap). For the most recent prescribing information and fact sheets, please visit